Spectrum of clinical features and type IV collagen α-chain distribution in Chinese patients with Alport syndrome

Nephrology Dialysis Transplantation

Volumn 21, Issue 11, 2006, Pages 3146-3154

  Wei, Gong ^a   Zhihong, Liu ^a   Huiping, Chen ^a   Caihong, Zeng ^a   Zhaohong, Chen ^a   Leishi, Li ^a  

^a JINLING HOSPITAL   (China)

Author keywords

Alport syndrome (AS); Indirect immunofluorescence; Phenotype; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4;

ADOLESCENT; ADULT; ALPHA CHAIN; ALPORT SYNDROME; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EYE DISEASE; FEMALE; FOCAL GLOMERULONEPHRITIS; GENE EXPRESSION; GENE LOCATION; HEARING IMPAIRMENT; HEMATURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; INCIDENCE; INFANT; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RETROSPECTIVE STUDY; TISSUE DISTRIBUTION; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ADULT; AUTOANTIGENS; CHILD; CHILD, PRESCHOOL; CHINA; COHORT STUDIES; COLLAGEN TYPE IV; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NEPHRITIS, HEREDITARY; PHENOTYPE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 33750028025     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl394     Document Type: Article

References (34)

1. Alport AC. Hereditary familial congenital haemorrhagic nephritis. Br Med J 1927; 1: 504-506
2. Kashtan CE, Michael AF. Alport syndrome: From bedside to genome to bedside. Am J Kidney Dis 1993; 22: 627-640
3. Hudson BG. The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family. J Am Soc Nephrol 2004; 15: 2514-2517
4. Tryggvason K. Mutations in type IV collagen genes and Alport phenotypes. Molecular Pathology and Genetics of Alport Syndrome, Basel, Karger: 1996; 154-171
5. Lemmink HH, Schröder CH, Monnens LAH, Smeets HJM. The clinical spectrum of type IV collagen mutations. Hum Mutat 1997; 9: 477-499
6. Mochizuki T, Lemmink HH, Mariyama M et al. Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 1994; 8: 77-82
7. Lemmink HH, Mochizuki T, van den Heuvel LP et al. Mutations in the type IV collagen α3(COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 1994; 3: 1269-1273
8. Knebelmann B, Forestier L, Drouot L et al. Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet 1995; 4: 675-679
9. Jais JP, Knebelmann B, Giatras I et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: A "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol 2003; 14: 2603-2610
10. Inoue Y, Nishio H, Shirakawa T et al. Detection of mutations in the COL4A5 gene in over 90% of male patients with X-linked Alport's syndrome by RT-PCR and direct sequencing. Am J Kidney Dis 1999; 34: 854-862
11. Plant KE, Green PM, Vetrie D, Flinter FA. Detection of mutations in COL4A5 in patients with Alport syndrome. Hum Mutations in COL4A5 in patients with Alport syndrome. Hum Mutat 1999; 13: 124-132
12. Martin P, Heiskari N, Pajari H et al. Spectrum of COL4A5 mutations in Finnish Alport syndrome patients. Hum Mutat 2000; 15: 579
13. Cheong HI, Park HW, Ha IS, Choi Y. Mutational analysis of COL4A5 gene in Korean Alport syndrome. Pediatr Nephrol 2000; 14: 117-121
14. Barker DF, Denison JC, Atkin CL, Gregory MC. Efficient detection of Alport syndrome COL4A5 mutations with multiplex genomic PCR-SSCP. Am J Med Genet 2001; 98: 148-160
15. Hertz JM, Juncker I, Persson U et al. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome. Hum Mutat 2001; 18: 141-148
16. Gross O, Netzer KO, Lambrecht R. Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome impact on clinical counseling. Nephrol dial transplant 2002; 17: 1217-1228
17. Jais JP, Knebelmann B, Giatras I et al. X-linked Alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 2000; l1: 649-657
18. Kashtan CE. Alport syndromes: Phenotypic heterogeneity of progressive hereditary nephritis. Pediatr Nephrol 2000; 14: 502-512
19. Gregory MC, Terreros DA, Barker DF et al. Alport syndrome - clinical phenotypes, incidence, and pathology. Contrib Nephrol 1996; 117: 1-28
20. Gubler MC, Knebelmann B, Beziau A et al. Autosomal recessive Alport syndrome: Immunohistochemical study of type IV collagen chain distribution. Kidney Int 1995; 47: 1142-1147
21. Boye E, Mollet G, Forestier et al. Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet 1998; 63: 1329-1340
22. Kalluri R, Shield CF, Todd P, Hudson BG, Neilson EG. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 1997; 99: 2470-2478
23. Nakanishi K, Yoshikawa N, Iijima K et al. Immunohistochemical study of α1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 1994; 46: 1413-1421
24. Kleppel MM, Kashtan C, Santi PA, Wieslander J, Michael AF. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis: Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen. Lab Invest 1989; 61: 278-289
25. Naito I, Kawai S, Nomura S et al. Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndrome. Kidney Int 1996; 50: 304-311
26. Kashtan CE, Kim Y. Distribution of the alpha 1 and alpha 2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int 1992; 42: 115-126
27. Pajari H, Kaariainen H, Muhonen T, Koskimies O. Alport's syndrome in 78 patients: Epidemiological and clinical study. Acta Paediatr 1996; 85: 1300-1306
28. Shunhua G, Jie D, Jiyun Y. The characteristic clinic manifestation and study actuality of Alport syndrome in China. Chin J Nephrol Dial Transplant 1999; 8: 71-73
29. Wei G, Zhihong L, hong Z et al. The relationship between the distribution features of type IV collagen a chains and the clinical phenotype in Alport syndrome. Chin J Nephrol Dial Transplant 2003; 12: 201-206
30. Chugh KS, Sakhuja V, Agarwal A et al. Hereditary nephritis (Alport's syndrome - clinical profile and inheritance in 28 kindreds. Nephrol Dial Transplant 1993; 8: 690-695
31. Zhou J, Leinonen A, Tryggvason K. Structure of the human type IV collagen COL4A5 gene. J Biol Chem 1994; 269: 6608-6614
32. Mazzucco G, De Marchi M, Monga G. Renal biopsy interpretation in Alport Syndrome. Semin Diagn Pathol 2002; 19: 133-145
33. Barsotti P, Muda AO, Mazzucco G et al. Distribution of α-chains of type IV collagen in glomerular basement membranes with ultrastructural alterations suggestive of Alport syndrome. Nephrol Dial Transplant 2001; 16: 945-952
34. Torra R, Tazon-Vega B, Ars E, Ballarin J. Collagen type IV (alpha3-alpha4) nephropathy: From isolated haematuria to renal failure. Nephrol Dial Transplant 2004; 19: 2429-2432